Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
Open accessThe DOI matches its Crossref record; 244 of the 246 references it cites were found in a registry or an index.
Abstract
Background.: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its diagnosis remain. Methods.: A task force supported by the American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America searched, selected, and synthesized relevant evidence. The evidence was then used as the basis for recommendations about the diagnosis of tuberculosis disease and LTBI in adults and children. The recommendations were formulated, written, and graded using the Grading, Recommendations, Assessment, Development and Evaluation (GRADE) approach. Results.: Twenty-three evidence-based recommendations about diagnostic testing for latent tuberculosis infection, pulmonary tuberculosis, and extrapulmonary tuberculosis are provided. Six of the recommendations are strong, whereas the remaining 17 are conditional. Conclusions.: These guidelines are not intended to impose a standard of care. They provide the basis for rational decisions in the diagnosis of tuberculosis in the context of the existing evidence. No guidelines can take into account all of the often compelling unique individual clinical circumstances.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, culture may lead to misclassification of some cases of extrapulmonary tuberculosis as ‘not tuberculosis', owing to the paucibacillary nature of the disease.”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“This means that culture may have low sensitivity for extrapulmonary tuberculosis overall and further that culture sensitivity may differ for different forms of extrapulmonary tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“A recent evidence synthesis reported sensitivities of 72% to 88% in lymph node tissue, 28% to 81% in pleural fluid, 90% in pleural tissue, and 31% to 56% in CSF. Specificity ranged from 90% to 100% (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“For the 'Summary of findings' tables for CSF and pleural fluid, we provide evidence using culture as the reference standard, which is considered the best reference standard for tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 3×
“These assays are promising, but are not yet commercially available [146, 159, 160].”
BackgroundMethodGrading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732 · cited 1×
“The emergence of drug-resistant tuberculosis has become apparent over the past 2 decades, and in particular, multidrug-resistant tuberculosis (MDR-TB; resistant to isoniazid and rifampin) and extensively drug-resistant tuberculosis (XDR-TB; resistant to isoniazid and rifampin, plus any fluoroquinolone and at least 1 o…”
BackgroundSelwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574 · cited 1×
“For example, individuals who have a prior latent infection with Mtb (not treated) and then acquire HIV infection will develop TB disease at an approximate rate of 5%–10% per year (in the absence of effective HIV treatment) [18, 19].”
Background(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,525
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Woods, G. L., Brown‐Elliott, B. A., Conville, P. S., Desmond, E. P., Hall, G. S., Lin, G., Pfyffer, G. E., Ridderhof, J. C., Siddiqi, S. H., Wallace, R. J., et al. (2011) · Cited by 1,136
Self-citationMolecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
Research works printed but not linked: 8
- World Health Organization, 2015, Global tuberculosis report 2015
- T-SPOT.TB: an aid in the diagosis of tuberculosis infection; package insert for in vitro diagnositic use
- Perez, 2005, Impact of screening for latent TB before initiating anti-TNF therapy in North America and Europe, Ann Rheum Dis, 64, 265
- US Food and Drug Administration, 2008, Medical devices: T-SPOT-TB—P070006
- Forbes, 2008, Laboratory detection and identification of mycobacteria; approved guideline
- Francis J. Curry National Tuberculosis Center and California Department of Public Health, 2008, Drug-resistant tuberculosis: a survival guide for clinicians
- World Health Organization, 2008, Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis (MDR-TB)
- Ena, 1990, The usefulness and limitations of adenosine deaminase in the diagnosis of tubercular pleurisy. A meta-analytical study [in Spanish], Med Clin (Barc), 95, 333
Cited by
Items 101–200 of 992
Mantica, G., Ambrosini, F., Riccardi, N., Vecchio, E., Rigatti, L., Rose, A. F. D., van der Merwe, A., Terrone, C., Bartoletti, R., & Bonkat, G. (2021) · Antibiotics · doi:10.3390/antibiotics10111399 · Cited by 40
“Moreover, it could concurrently provide data on TB drug susceptibility [26].”
Machine learning in the loop for tuberculosis diagnosis support
Orjuela-Cañón, Á. D., Jutinico, A. L., Awad, C., Vergara, E., & Palencia, M. A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.876949 · Cited by 51
Medical management of inflammatory bowel diseases
Hashash, J. G., Limdi, J. K., Shapiro, J. M., & Shah, S. A. (2025) · BMJ · doi:10.1136/bmj-2025-079050 · Cited by 61
Bae, S., Kim, Y., Kim, M.-J., Kim, J. H., Yun, S., Jung, J., Kim, M. J., Chong, Y. P., Kim, S., Choi, S., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002960 · Cited by 43
“18 19 Notably, the Society for Immunotherapy of Cancer (SITC) guideline recommends LTBI screening prior to initiating ICI 20 ; however, this recommendation was made considering the potential use of corticosteroids or tumor necrosis factor (TNF) inhibitors for the treatment of immune-related adverse…”
Coremans, L., & de Clerck, F. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0768-0 · Cited by 39
“peritoneal biopsies, under the condition that a negative result is not used to exclude peritoneal tuberculosis [11].”
BackgroundInfluentialDelemarre, E. M., van Hoorn, L., Bossink, A. W. J., Drylewicz, J., Joosten, S. A., Ottenhoff, T. H. M., Akkerman, O. W., Goletti, D., Petruccioli, E., Navarra, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.725447 · Cited by 39
Krishnamoorthy, Y., Ezhumalai, K., Murali, S., Rajaa, S., Jose, M., Sathishkumar, A., Soundappan, G., Horsburgh, C. R., Hochberg, N. S., Johnson, W. E., et al. (2021) · Tropical Medicine & International Health · doi:10.1111/tmi.13693 · Cited by 39
“Findings from other surveys done from India are also in line with our findings [23,24].”
ResultBTS clinical statement for the diagnosis and management of ocular tuberculosis
Kon, O. M., Beare, N. A. V., Connell, D. W., Damato, E. M., Gorsuch, T., Hagan, G., Perrin, F., Petrushkin, H., Potter, J., Sethi, C. S., et al. (2022) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2022-001225 · Cited by 38
A journey through infectious risk associated with ruxolitinib
Sant’Antonio, E., Bonifacio, M., Breccia, M., & Rumi, E. (2019) · British Journal of Haematology · doi:10.1111/bjh.16174 · Cited by 39
“According to international guidelines (Lewinsohn et al, 2017), there are insufficient data to recommend a preference for either a TST or an IGRA as the first-line diagnostic test in immunocompromised patients: it has been suggested that a combined TST-IGRA test is probably the best way to improve…”
LIOFeron®TB/LTBI: A novel and reliable test for LTBI and tuberculosis
Bella, C. D., Spinicci, M., Alnwaisri, H. F. M., Bartalesi, F., Tapinassi, S., Mencarini, J., Benagiano, M., Grassi, A., D’Elios, S., Troilo, A., et al. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.12.012 · Cited by 38
Development and validation of a prognostic score to predict tuberculosis mortality
Nguyen, D. T., & Graviss, E. A. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.02.009 · Cited by 37
Sharninghausen, J. C., Shapiro, A. E., Koelle, D. M., & Kim, H. N. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy184 · Cited by 37
“TB (Oxford Immunotec Limited), are Food and Drug Administration–approved and recommended for LTBI testing [3].”
The risk for opportunistic infections in inflammatory bowel disease with biologics: an update
Borman, Z. A., Côté-Daigneault, J., & Colombel, J. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1530983 · Cited by 37
Sakai, M., Higashi, M., Fujiwara, T., Uehira, T., Shirasaka, T., Nakanishi, K., Kashiwagi, N., Tanaka, H., Terada, H., & Tomiyama, N. (2021) · Japanese Journal of Radiology · doi:10.1007/s11604-021-01150-4 · Cited by 43
Robison, H. M., Chapman, C. A., Zhou, H., Erskine, C. L., Theel, E. S., Peikert, T., Arlehamn, C. S. L., Sette, A., Bushell, C., Welge, M. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99754-3 · Cited by 42
Jiang, F., Peng, C., Cheng, P., Wang, J., Lian, J., & Gong, W. (2023) · Vaccines · doi:10.3390/vaccines11040856 · Cited by 42
“Latent tuberculosis infection (LTBI) is “a state of persistent immune response to stimulation by MTB antigens with no evidence of clinically manifest active TB” [13] and “refers to a host who is TB immunoreactive in the absence of TB disease” [14].”
BackgroundInfections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies
Thomas, Κ., & Vassilopoulos, D. (2020) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.31.1.129 · Cited by 37
Aiello, A., Fard, S. N., & Goletti, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1244556 · Cited by 41
“Microscopy, culture, molecular tests such as Gene-Xpert, and chest Xray (2, 92, 93).”
Advanced imaging tools for childhood tuberculosis: potential applications and research needs
Jain, S. K., Andronikou, S., Goussard, P., Antani, S., Gómez‐Pastrana, D., Delacourt, C., Starke, J. R., Ordoñez, A. A., Jean‐Philippe, P., Browning, R., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30177-8 · Cited by 43
Ho, C. S., Feng, P.-J. I., Narita, M., Stout, J. E., Chen, M., Pascopella, L., Garfein, R. S., Reves, R. R., Katz, D. J., Flood, J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00145-6 · Cited by 36
Self-citationEvaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States
Holzman, S. B., Perry, A., Saleeb, P. G., Pyan, A., Keh, C. E., Salcedo, K. L., Narita, M., Ahmed, A. I., Miller, T. L., Pettit, A. C., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac248 · Cited by 36
Jo, Y., Shrestha, S., Gomes, I., Marks, S. M., Hill, A. N., Asay, G. R. B., & Dowdy, D. W. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa857 · Cited by 41
Zurac, S., Mogodici, C., Poncu, T., Trăşcău, M., Popp, C. G., Nichita, L., Cioplea, M. D., Ceachi, B., Sticlaru, L., Cioroianu, A., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12061484 · Cited by 43
“Bacteriological tests are more successful in identifying mycobacteria than pathology (up to 50–80% more sensitivity for bacteriology compared with histopathology) [28] but the main drawback of the method is the time required by cultures—average of 14–21 days but it is not unusual to take up to 6–8 weeks [29].”
de Nooy, A., Ockhuisen, T., Korobitsyn, A., Khan, S. A., Rühwald, M., Ismail, N. A., Kohli, M., & Nichols, B. E. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00178-5 · Cited by 34
do Prado, T. N., Riley, L. W., Sanchez, M. N., Fregona, G. C., Nóbrega, R. L. P., Possuelo, L. G., Zandonade, E., Locatelli, R. L., de Souza, F. M., Rajan, J. V., et al. (2017) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00154916 · Cited by 34
Epidemiology of Tuberculosis in the United States
Langer, A. J., Navin, T. R., Winston, C. A., & LoBue, P. A. (2019) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.07.001 · Cited by 34
Self-citationNathavitharana, R. R., Lederer, P. A., Chaplin, M., Bjerrum, S., Steingart, K. R., & Shah, M. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014641 · Cited by 42
“The agreed-upon best reference standard for pulmonary tuberculosis is sputum culture (Lewinsohn 2017).”
BackgroundZaizen, Y., Kanahori, Y., Ishijima, S., Kitamura, Y., Yoon, H., Ozasa, M., Mukae, H., Bychkov, A., Hoshino, T., & Fukuoka, J. (2022) · Diagnostics · doi:10.3390/diagnostics12030709 · Cited by 38
“4 million deaths worldwide annually [1,2].”
InfluentialBella, C. D., Spinicci, M., Grassi, A., Bartalesi, F., Benagiano, M., Truthmann, K., Tapinassi, S., Troilo, A., D’Elios, S., Alnwaisri, H. F. M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197825 · Cited by 34
Early and opposing neutrophil and CD4 T cell responses shape pulmonary tuberculosis pathology
Gern, B. H., Klas, J. M., Foster, K. A., Kanagy, M. E., Cohen, S. B., Plumlee, C. R., Duffy, F. J., Neal, M. L., Halima, M., Gustin, A. T., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250161 · Cited by 45
“Thus, understanding how to prevent this destructive pathology from developing could lead to new strategies to curb severe manifestations of disease (Allwood et al., 2021; Hernandez-Romieu et al., 2019; Lewinsohn et al., 2017; Ravimohan et al., 2018; Benator et al., 2002).”
Pan, X., Yang, S., Deighton, M. A., Qu, Y., Hong, L., & Su, F. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00444 · Cited by 33
“Such two-step diagnostic criteria were designed to predict the presence of active pulmonary TB and establish a credible reference standard, as the well-accepted high specificity (∼100%) of mycobacterial culture (the 1st criterion) allow very few “false-positive” cases (Lewinsohn et al., 2017), while the 2nd criterion…”
BackgroundMethodCD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status
Lee, M., Chang, C., Chang, L., Chuang, Y., Sun, H., Wang, J., & Wang, J. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.01.007 · Cited by 33
Liu, X., Xia, L., Song, B., Wang, H., Qian, X.-Q., Wei, J., Li, T., Xi, X., Song, Y., Li, S., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.10.036 · Cited by 33
Kim, J., Park, B. G., Lim, D. H., Jang, W. S., Nam, J., Mihn, D.-C., & Lim, C. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244753 · Cited by 33
“According to the recent guideline, all of acid-fast bacilli (AFB) smear microscopy, liquid and solid culture for MTB, and nucleic acid amplification tests (NAAT) were recommended for initial clinical sample to diagnose infection of MTB [2].”
MethodGlucocorticoids for therapeutic immunosuppression: Clinical pearls for the practicing neurologist
Galati, A., Brown, E. S., Bove, R. M., Vaidya, A., & Gelfand, J. M. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120004 · Cited by 35
Treatment of Latent Tuberculosis Infection
Haley, C. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.tnmi7-0039-2016 · Cited by 33
“If the chest radiograph is abnormal or pulmonary symptoms are present, a sputum sample for smear and culture of acid-fast bacilli should also be obtained, and further evaluation and management of suspected TB should be conducted according to current guidelines (20, 47).”
Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection
Chin, K. L., Anibarro, L., Sarmiento, M. E., & Acosta, A. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8020089 · Cited by 32
“The American Thoracic Society, Infectious Diseases Society of America, and Centers for Disease Control and Prevention (ATS/IDSA/CDC) have recommended screening tests using either TST or IGRAs for those that are likely to be infected with Mtb [70].”
Comprehensive management of pneumonia in older patients
Putot, A., Garin, N., Rello, J., & Prendki, V. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.02.025 · Cited by 42
Actualización del tratamiento de la tuberculosis en niños
Mellado, M. J., Santiago, B., Baquero‐Artigao, F., Pérez, D. M., Pérez, R. P., Méndez-Echevarría, A. M., Amador, J. T. R., Gómez‐Pastrana, D., & Noguera‐Julián, A. (2017) · Anales de Pediatría · doi:10.1016/j.anpedi.2017.05.013 · Cited by 32
“Isoniacida 10 (7-15)a,b 300 Rifampicina 15 (10-20)a 600 Pirazinamida 35 (30-40) 2.”
Wu, D., Chen, C., Liu, T., Jia, Y., Wan, Q., & Peng, J. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00411-z · Cited by 32
“Ceftazidime avibactam has been reported to have better effects than TGC, thus being approved to treat CR-GNB infections in China since May 21, 2019 [36, 37].”
BackgroundDefining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis
Nziza, N., Cizmeci, D., Davies, L. R. L., Irvine, E. B., Jung, W., Fenderson, B. A., de Kock, M., Hanekom, W. A., Franken, K. L. M. C., Day, C. L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856906 · Cited by 34
Chen, H.-W., Kuo, Y.-W., Chen, C., Chang, C.-H., Wang, S.-M., Chien, Y., Chen, J., Chen, J.-P., Chang, C., Wei, Y., et al. (2024) · The Oncologist · doi:10.1093/oncolo/oyad340 · Cited by 35
Chan, G. H. J., Gwee, Y. X., Low, J. L., Huang, Y., Chan, Z. Y., Choo, J. R. E., Ngoi, N. Y. L., Ang, Y. L. E., Muthu, V., Chong, W. Q., et al. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.05.020 · Cited by 32
Jin, W., Pan, J., Miao, Q., Ma, Y., Zhang, Y., Huang, Y., Yao, Y., Su, Y., Wang, Q., Wang, M., et al. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-2274 · Cited by 31
“A positive mycobacterial culture requires approximately 100 organisms per mL, and culture has reduced sensitivity in paucibacillary samples (such as serous fluid, BALF, and tissue homogenate) and samples from patients who previously received anti-TB therapy (14,16,17).”
Chen, Y., Tan, D., Xu, Y., Wang, B., Li, X., Cai, X., Li, M., Tang, C., Wu, Y., Shu, W., et al. (2019) · Patient Education and Counseling · doi:10.1016/j.pec.2019.09.007 · Cited by 33
What pulmonologists need to know about extrapulmonary tuberculosis
Natali, D., Cloatre, G., Brosset, C., Verdalle, P., Fauvy, A., Massart, J.-P., Van, Q. V., Gerard, N., Dobler, C. C., & Hovette, P. (2020) · Breathe · doi:10.1183/20734735.0216-2020 · Cited by 34
“For example, in lymphocytic pleural, pericardial, peritoneal and joint effusions, an adenosine desaminase (ADA) level>40 g·L−1 has a high positive predictive value for the diagnosis of tuberculosis in a patient with a high pre-test probability of tuberculosis, whereas an ADA level<40 g·L−1 rules out tuberculosis with…”
BackgroundInfluentialNast, A., Altenburg, A., Augustin, M., Boehncke, W., Härle, P., Klaus, J., Koza, J., Mrowietz, U., Ockenfels, H. M., Philipp, S., et al. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14507_g · Cited by 36
Park, M., Lee, Y., Kim, S., Kim, Y.-J., Kim, Y., Kim, Y., & Kim, H. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-07996-5 · Cited by 32
“Second, because of these limitations of AFB staining, the gold standard to distinguish between MTB and NTM is a culture in liquid or solid media [7].”
Prevalence and risk factors of drug‐resistant extrapulmonary tuberculosis
Boonsarngsuk, V., Mangkang, K., & Santanirand, P. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12779 · Cited by 32
“At this time, FDA has not yet approved the rapid molecular DST for use with extrapulmonary specimens.(18) Due to the nature of the retrospective study, there were some limitations in our report.”
BackgroundMethodResultInfluentialDiabetes as a risk factor for tuberculosis disease
Franco, J. V. A., Bongaerts, B. W. C., Metzendorf, M., Risso, A., Guo, Y., Silva, L. P., Boeckmann, M., Schlesinger, S., Damen, J. A., Richter, B., et al. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd016013.pub2 · Cited by 72
Kaur, M., Singapura, P., Kalakota, N., Cruz, G., Shukla, R., Ahsan, S., Tansel, A., Thrift, A. P., & El‐Serag, H. B. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.11.038 · Cited by 29
Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay
Siegel, S. A. R., Cavanaugh, M., Ku, J. H., Kawamura, L. M., & Winthrop, K. L. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00629-18 · Cited by 30
Yang, Y. L., Wang, H.-J., Hu, W., Bai, G., & Hua, C. (2022) · Diagnostics · doi:10.3390/diagnostics12020453 · Cited by 29
Bukhary, Z. A. A., Amer, S. M., Emara, M. M., Abdalla, M. E., & Ali, S. A. M. (2018) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2018.90 · Cited by 30
Sun, W., Lu, Z., & Yan, L. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.11.165 · Cited by 31
Long, H., Hu, Q., Lei, T., Zhang, Y., Lei, P., & Hu, Y. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100338 · Cited by 28
Bacterial and Viral Infection and Sepsis in Kidney Transplanted Patients
Mella, A., Mariano, F., Dolla, C., Gallo, E., Manzione, A. M., Vico, M. C. D., Cavallo, R., Rosa, F. G. D., Costa, C. S., & Biancone, L. (2022) · Biomedicines · doi:10.3390/biomedicines10030701 · Cited by 28
“Tubercolosis [79,86,87] Epstein-Barr Virus (EBV) [120]”
Park, C. H., Park, J. H., & Jung, Y. S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030507 · Cited by 28
“, 5 mm for patients on IST and 10 mm for those not on IST) [15], whereas IST decreased the TST-positive rate in the meta-analysis of studies with fixed cutoff values (e.”
InfluentialMigration, TB control and elimination: Whom to screen and treat ☆
Rendón, A., Centis, R., Zellweger, J. P., Solovič, I., Torres-Duque, C. A., Cordeiro, C. R., Mello, F. C. D. Q., Manissero, D., & Sotgiu, G. (2017) · Pulmonology · doi:10.1016/j.rppnen.2017.11.007 · Cited by 28
Yulvina, R., Putra, S. A., Rizkinia, M., Pujitresnani, A., Tenda, E. D., Yunus, R. E., Djumaryo, D. H., Yusuf, P. A., & Valindria, V. V. (2024) · Computers · doi:10.3390/computers13120343 · Cited by 44
Tuberculosis: a focused review for the emergency medicine clinician
Long, B., Liang, S. Y., Koyfman, A., & Gottlieb, M. A. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.12.040 · Cited by 39
Calzada‐Hernández, J., Antón, J., de Carpi, J. M., López‐Montesinos, B., Penadés, I. C., Donat, E., Cuadros, E. N., Alonso, J. B., Mellado, M. J., Baquero‐Artigao, F., et al. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04640-3 · Cited by 27
Zhu, Y., Zhao, W., Yang, X., Zhang, Y., Lin, X., Weng, X., Wang, Y., Cheng, C., Chi, Y., Wei, H., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1055996 · Cited by 32
“on the contrary, none of the JCV, VN, and TE have been thought to persist in healthy individuals, and the detection of pathogen DNA from sterile material generally proves clinical diseases (Luft and Chua, 2000; Lewinsohn et al., 2017; Donnelly et al., 2020).”
BackgroundLiu, M., Li, W., Qiao, W., Liang, L., & Wang, Z. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1044426 · Cited by 29
Shobha, V., Chandrashekara, S., Rao, V. K. R., Desai, A. M., Jois, R., Dharmanand, B. G., Kumar, S., Kumar, P., Dharmapalaiah, C., Mahendranath, K. M., et al. (2018) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13376 · Cited by 27
Lu, Y., Zhu, Y., Shen, N., Tian, L., & Sun, Z. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.01.030 · Cited by 27
Chen, H., Nakagawa, A., Takamori, M., Abe, S., Ueno, D., Horita, N., Kato, S., & Seki, N. (2022) · Infection · doi:10.1007/s15010-022-01789-9 · Cited by 26
“IGRA rather than TST was recommended by the Centers for Disease Control and Prevention (CDC) in individuals 5 years or older upon the likelihood of infection with Mtb and the likelihood of progression to TB disease if infected [1].”
BackgroundMethodInfluentialCurrent status of treatment of latent tuberculosis infection in India
Saha, S., Kumar, A., Saurabh, K., Shankar, S. H., Kashyap, A., Nischal, N., Biswas, A., & Wig, N. (2020) · Indian Journal of Medical Sciences · doi:10.25259/ijms_18_2019 · Cited by 26
Li, Y., Bian, W., Wu, S., Zhang, J., & Li, D. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1224993 · Cited by 28
Wong, N. S., Leung, C. C., Chan, K. C.-W., Chan, W. K., Lin, A. W. C., & Lee, S. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-46570-5 · Cited by 25
Malkova, A. M., Starshinova, A. A., Zinchenko, Y. S., Basantsova, N. Y., Mayevskaya, V. A., Yаblonskiy, P. K., & Shoenfeld, Y. (2020) · ERJ Open Research · doi:10.1183/23120541.00155-2020 · Cited by 26
Prevalence of Latent Tuberculosis Infection in the Middle East and North Africa: A Systematic Review
Barry, M. A. (2021) · Pulmonary Medicine · doi:10.1155/2021/6680651 · Cited by 25
Deng, J., Liu, L., Yang, Q., Wei, C., Zhang, H., Xin, H., Pan, S., Liu, Z., Wang, D., Liu, B., et al. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108876 · Cited by 28
A narrative review of tuberculosis in the United States among persons aged 65 years and older
Wu, I., Chitnis, A. S., & Jaganath, D. (2022) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2022.100321 · Cited by 25
“Current practice guidelines recommend the use of IGRAs over TSTs in older patients [22].”
MethodPagaduan, J. V., & Altawallbeh, G. (2023) · Advances in clinical chemistry · doi:10.1016/bs.acc.2023.03.003 · Cited by 37
“mined three diameter cut-points (5, 10 and 15 mm) to define a positive reaction based on certain risk factors for TB infection (Table 3) [84].”
BackgroundMethodInfluentialKabir, S., Uddin, M. K. M., Chisti, M. J., Fannana, T., Haque, M. E., Uddin, M. R., Banu, S., & Ahmed, T. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.01.015 · Cited by 28
Luo, L., Cao, W., Chen, W., Zhang, R., Jing, L., Chen, H., Yu, F., & Yue, J. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0120-3 · Cited by 26
Lo, C., Wu, Y., Li, Y., & Lee, C.-C. (2020) · Applied Sciences · doi:10.3390/app10124059 · Cited by 24
“Tissue slides are examined under 400× magnifications or even higher magnification (1000×) with oil immersion, which is a very laborious and time-consuming task [3,9].”
Ayers, T., Hill, A. N., Raykin, J., Mohanty, S., Belknap, R., Brostrom, R. J., Khurana, R., Lauzardo, M., Miller, T. L., Narita, M., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.4769 · Cited by 24
Self-citationBasu, S., & Chakraborty, S. (2025) · Microorganisms · doi:10.3390/microorganisms13010178 · Cited by 30
Mycobacterial Infections in Patients With Chronic Kidney Disease and Kidney Transplantation
Cahuayme‐Zuniga, L., & Brust, K. B. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2018.09.004 · Cited by 23
Kim, K. H., Kang, J., & Ahn, J. G. (2021) · Scientific Reports · doi:10.1038/s41598-021-86053-0 · Cited by 23
Aptamer-Based Diagnostic Systems for the Rapid Screening of TB at the Point-of-Care
Martin, D. R., Sibuyi, N. R. S., Dube, P., Fadaka, A. O., Cloete, R. E. A., Onani, M. O., Madiehe, A. M., & Meyer, M. (2021) · Diagnostics · doi:10.3390/diagnostics11081352 · Cited by 25
“The QFT-GIT test measures the IFN-γ concentration, whilst the TSPOT determines the number of cells actively producing IFN-γ.”
BackgroundMethodInfluentialThe spectrum of tuberculosis of the spine in pediatric age group: a review
Chatterjee, S., & Banta, A. (2018) · Child s Nervous System · doi:10.1007/s00381-018-3891-x · Cited by 23
The evolving research agenda for paediatric tuberculosis infection
Seddon, J. A., Whittaker, E., Kampmann, B., Lewinsohn, D. A., Osman, M., Hesseling, A. C., Rustomjee, R., & Amanullah, F. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30787-4 · Cited by 23
Self-citationMello, F. C. D. Q., Silva, D. R., & Dalcolmo, M. P. (2018) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562017000000450 · Cited by 23
“Therefore, the tuberculosis control strategy should ensure provision of services for early diagnosis and proper treatment of all forms of tuberculosis affecting people of all ages.(2,4) New, safer, affordable, and more effective drugs allowing treatment regimens that are shorter in duration and easier to administer ar…”
BackgroundLaboratory Cross-Contamination of Mycobacterium tuberculosis: A Systematic Review and Meta-analysis
Barac, A. M., Karimzadeh-Esfahani, H., Pourostadi, M., Rahimi, M. T., Ahmadpour, E., Rashedi, J., Mahdavipoor, B., Kafil, H. S., Spotin, A., Abate, K. H., et al. (2019) · Lung · doi:10.1007/s00408-019-00241-4 · Cited by 22
“The American Thoracic Society, Infectious Disease Society of America, and Centers for Disease Control and Prevention recently issued Guidelines for the diagnosis of tuberculosis, suggesting the need of confirmatory tests following an initial positive mycobacterial culture, acknowledging that false-positive results are…”
BackgroundCao, D., Zhang, Z., Yang, Z. Y., Ma, S., Sun, Z., Duan, H., Zhu, B., & Zhao, F. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4238-2 · Cited by 22
A Prospective Evaluation of Xpert MTB/RIF Ultra for Childhood Pulmonary Tuberculosis in Uganda
Jaganath, D., Wambi, P., Reza, T. F., Nakafeero, J., Oumo, E. A., Kiconco, E., Nanyonga, G., Nsereko, M., Sekadde, M. P., Nabukenya-Mudiope, M. G., et al. (2020) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piaa159 · Cited by 24
“This may have biased performance, although all sample types used are recommended under the current guidelines for TB evaluation in children [25].”
Friedman, S., Caddle, S., Motelow, J. E., Meyer, D. D., & Lane, M. M. (2021) · Pediatric Quality and Safety · doi:10.1097/pq9.0000000000000419 · Cited by 26
Lim, T. K., & Siow, W. T. (2017) · Respirology · doi:10.1111/resp.13137 · Cited by 25
Zhou, Y., Du, J., Hou, H., Lu, Y., Yu, J., Mao, L., Feng, W., & Sun, Z. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00457 · Cited by 22
“Other methods, such as microscopy of acid-fast staining (AFS) and culture for Mtb and nucleic acid detection technologies, all have limitations to meet the clinical requirements (Lewinsohn et al., 2016).”
MethodRapid one-step protein extraction method for the identification of mycobacteria using MALDI-TOF MS
Rotcheewaphan, S., Lemon, J. K., Desai, U. U., Henderson, C. M., & Zelazny, A. M. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.03.004 · Cited by 22
Cryptococcosis Associated With Biologic Therapy: A Narrative Review
Li, X., Paccoud, O., Chan, K. H., Yuen, K., Manchon, R., Lanternier, F., Slavin, M. A., van de Veerdonk, F. L., Bicanic, T. A., & Lortholary, O. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae316 · Cited by 22
“Due to the inhibition of the formation and maintenance of granulomas [157], TNF-α inhibition increases the risk of infection by intracellular pathogens that are normally contained by granulomatous inflammation, most notably, tuberculosis, histoplasmosis, and coccidioidomycosis [158–160].”
BackgroundTuberculosis treatment for children: An update
Mellado, M. J., García, B. S., Baquero‐Artigao, F., Pérez, D. M., Pérez, R. P., Méndez-Echevarría, A. M., Amador, J. T. R., Durán, D. G.-P., & Noguera‐Julián, A. (2017) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2017.05.001 · Cited by 21
“-- No known contact with an active TB source, but positive TST and/or IGRA results, especially in children aged less than 5 years or who are immunosuppressed.(17)”
BackgroundRiestra, S., Taxonera, C., Zabana, Y., Carpio, D., Beltrán, B., Mañosa, M., Gutiérrez, A., & Acosta, M. B. (2020) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2020.04.006 · Cited by 21
Occupational Respiratory Infections
de Perio, M. A., Kobayashi, M., & Wortham, J. M. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.08.003 · Cited by 21
“To evaluate for TB disease, medical providers should perform a thorough diagnostic evaluation on all persons with positive tests for TB infection; this diagnostic evaluation should include a medical history and physical exam, chest radiography, and, in certain circumstances, acid-fast bacilli (AFB) smear microscopy, c…”
MethodCollins, J. M., Stout, J. E., Ayers, T., Hill, A. N., Katz, D. J., Ho, C. S., Blumberg, H. M., & Winglee, K. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1662 · Cited by 21
“Although national guidelines recommend that persons from countries with high TB burdens be screened and treated for LTBI [9, 10], only a small fraction is screened, primarily by local health departments in the context of contact tracing [11–13].”
Ocaña‐Guzmán, R., Téllez-Navarrete, N. A., Ramón‐Luing, L. A., Herrera, I., Ita, M. D., Carrillo-Alduenda, J. L., Choreño-Parra, J. A., Quero, K. M., Zúñiga, J., & Chávez‐Galán, L. (2021) · Journal of Immunology Research · doi:10.1155/2021/6654220 · Cited by 21
“Pulmonary TB diagnosis relied on combined clinical criteria, chest X-ray images, acid-fast bacilli smear-positive staining, and Mtb-positive cultures in sputum samples [26].”
MethodAkalu, G. T., Tessema, B., & Petros, B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277145 · Cited by 21
Metadata
- Authors
- Lewinsohn, D. M., Leonard, M. K., LoBue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., Keane, J., Lewinsohn, D. A., Loeffler, A. M., Mazurek, G. H., O’Brien, R. J., Pai, M., Richeldi, L., Salfinger, M., Shinnick, T. M., Sterling, T. R., Warshauer, D. M., & Woods, G. L.
- Affiliations
- Oregon Health & Science University (US)
- Emory University School of Medicine and
- Centers for Disease Control and Prevention (US)
- Denver Public Health (US)
- National Jewish Health (US)
- California Department of Public Health (US)
- St. James's Hospital (IE)
- Francis J. Curry International TB Center, San Francisco, California;
- FIND (CH)
- McGill University (CA)
- University of Southampton (GB)
- Vanderbilt University (US)
- Wisconsin State Laboratory of Hygiene, Madison, and
- University of Arkansas for Medical Sciences (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-08
- Volume
- 64
- Issue
- 2
- Pages
- e1-e33
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5504475
- OpenAlex
- W2559832962
- Cited by
- 992
- References
- 246
- Citations by year
- 2026: 65 · 2025: 81 · 2024: 91 · 2023: 101 · 2022: 115 · 2021: 142 · 2020: 133 · 2019: 110 · 2018: 96 · 2017: 55 · 2016: 1
- FWCI
- 80.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis diagnosis, latent tuberculosis infection, pulmonary tuberculosis, extrapulmonary tuberculosis, Mycobacterium tuberculosis, diagnostic testing, children, adults
- MeSH terms
- Adult, Age Factors, Child, Humans, Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Pulmonary, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.